Vimarsana
Biggest News Aggregation in the World

Page 3 - Kickback Statute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kickback Statute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kickback Statute Today - Breaking & Trending Today

How to Avoid Violating Stark Law for Ambulatory Surgery Centers - Vimarsana News

How to Avoid Violating Stark Law for Ambulatory Surgery Centers

Under the Stark Law, physicians can be held liable if they refer patients to anyone with whom they have a financial relationship. it is critical you are not in violation of the Stark Law when you open, invest in, or refer a patient to an ambulatory surgery center.

Unsealed suits against Rossi, Reditus allege widespread fraud and corruption - Vimarsana News

Unsealed suits against Rossi, Reditus allege widespread fraud and corruption

PEORIA, Ill. (WMBD) — Two recently unsealed federal lawsuits allege massive fraud and grift committed by Aaron Rossi and his company, Reditus Laboratories, which resulted in taxpayers being bilked out of hundreds of millions of dollars. The suits, filed last year in U.S. District Court in Peoria by two whistleblowers on behalf of the the […]

Cara N. Ludwig Healthcare Lawyer Nelson Mullins Raleigh - Vimarsana News

Cara N. Ludwig Healthcare Lawyer Nelson Mullins Raleigh

Cara is an experienced healthcare transactional attorney known for her results-oriented approach and emphasis on helping clients achieve their ultimate goals.

Related Topics:
Kickback Statute
Regeneron V. Mylan – Update On Aflibercept BPCIA Litigation - Patent - Vimarsana News

Regeneron V. Mylan – Update On Aflibercept BPCIA Litigation - Patent

As we previously reported, Regeneron's BPCIA case against Mylan regarding Mylan's proposed aflibercept biosimilar is proceeding on an expedited schedule, with a two-week trial scheduled to begin on

Source: mondaq.com
Regeneron v. Mylan - Update on Aflibercept BPCIA Litigation | Goodwin - Vimarsana News

Regeneron v. Mylan - Update on Aflibercept BPCIA Litigation | Goodwin

As we previously reported, Regeneron’s BPCIA case against Mylan regarding Mylan’s proposed aflibercept biosimilar is proceeding on an expedited schedule, with a two-week trial scheduled...